ABOUT THE JOURNAL

Aims and scope of journal

Gene Therapy covers both the research and clinical applications of the new genetic therapy techniques currently being developed. Over the last decade, gene therapy protocols have entered clinical trials in increasing numbers and as they cover a wide spectrum of diseases, these studies promise to unite the diverse organ-based specialities into which modern medicine has become divided. Gene Therapy covers all aspects of gene therapy as applied to human disease, including:

• novel technological developments for gene transfer, control and silencing
• basic science studies of mechanisms of gene transfer and control of expression
• preclinical animal model systems and validation studies
• clinical trial reports which have significant impact for the field
• gene-based vaccine development and applications
• cell-based therapies including all aspects of stem cells and genetically modified cellular approaches

Impact Factor

2008 Impact Factor: 4.492*

Rank:
10/82 Medicine, Research & Experimental
15/144 Biotechnology & Applied Microbiology
24/138 Genetics & Heredity
61/276 Biochemistry & Molecular Biology

*2008 Journal Citation Reports (Thomson Reuters, 2009)

Abstracted/indexed in

BIOBASE/Current Awareness in Biological Sciences
Biotechnology Citation Index
Chemical Abstracts
Current Contents
Current Contents/Life Sciences
Derwent's Biotechnology Abstracts
Derwent's Gene Therapy Database
EMBASE/Excerpta Medica
MEDLINE/Index Medicus
MEDLARS
Science Citation Index

ISSN and eISSN

The international standard serial number (ISSN) for Gene Therapy is 0969-7128 and the electronic international standard serial number (eISSN) is 1476-5462.

Editors

USA Editor

J Glorioso, USA

European Editor

N Lemoine, UK

Reviews Editor

J Rossi, USA

Editorial Board

SM Albelda, USA
R Alemany, Spain
R Ali, UK
S Aliño, Spain
E Alton, UK
A Amalfitano, USA
D Anderson, USA
A Baker, UK
C Baum, Germany
J-P Behr, France
T Blankenstein, Germany
M Black, USA
DM Bodine, USA
J Bubenik, Czech Republic
B Byrne, USA
X Cao, China
MC Capogrossi, Italy
M G Castro, UK
J Chamberlain, USA
Y Chernajovsky, UK
WH Colledge, UK
MKL Collins, UK
M Conese, Italy
K Cornetta, USA
C Coutelle, UK
T Cripe, USA
A Crottogini, Argentina
RG Crystal, USA
D Curiel, USA
O Danos, France
B Davidson, USA
KE Davies, UK
RJ Debs, USA
ML Degos, France
N DeLuca, USA
K Doronin, USA
D Duan, USA
S Eck, USA
L Eisenbach, Israel
C Evans, USA
E Falck-Pedersen, USA
F Farzaneh, UK
MC Favrot, France
HJ Federoff, USA
B Fehse, Germany
D Fink, USA
TR Flotte, USA
C Fraefel, Switzerland
J Fujimoto, Japan
F Gage, USA
G Gao, USA
D Gazit, Israel
S Ghivizzani, USA
W Goins, USA
J M Goldman, UK
U Griesenbach, UK
B Groner, Germany
D Gruenert, USA
WH Guenzburg, Austria
R E Hawkins, UK
A Hemminki, Finland
R Herzog, USA
R C Hoeben, The Netherlands
EP Hoffman, USA
L Huang, USA
J Huard, USA
J Iacomini, USA
MJ Imperiale, USA
C June, USA
HP Kiem, USA
R Kotin, USA
J Leiden, USA
AML Lever, UK
D Liu, USA
H Loessner, Germany
PR Lowenstein, USA
L Luzzatto, Italy
I McNeish, UK
A Melman, USA
AD Miller, USA
S Mohapatra, USA
PA Morel, USA
R Morgan, USA
R Morishita, Japan
JD Mountz, USA
D Muruve, Canada
N Muzyczka, USA
H Nakai, USA
L Naldini, Italy
BW O'Malley, USA
M S Penn, USA
M Perricaudet, France
K Ponder, USA
S Ponnazhagan, USA
SD Rabkin, USA
S Raper, USA
Y Raphael, USA
C Reis e Sousa, UK
J Reiser, USA
P Robbins, USA
SJ Russell, USA
M Sadelain, USA
Y Saeki, USA
J Samulski, USA
A Scaria, USA
P Schratzberger, Austria
PF Searle, UK
LW Seymour, UK
CJ Springer, UK
A Srivastava, USA
FC Szoka Jr, USA
H Tahara, Japan
J Teissie, France
T Townes, USA
J Tremblay, Canada
D Valerio, The Netherlands
T VandenDriessche, Belgium
G Vassaux, France
MA Vega, Argentina
RG Vile, UK
YH Wang, China
K Webster, USA
DJ Wells, UK
RJ Whitley, USA
TJ Wickham, USA
JM Wilson, USA
JH Wolfe, USA
JA Wolff, USA
TC Wu, USA
X Xiao, USA
S Ylä-Herttuala, Finland